comparemela.com

Latest Breaking News On - Erics fain - Page 1 : comparemela.com

Procyrion Announces First Patient Enrollments in the DRAIN-HF Pivotal IDE Trial for Aortix Percutaneous Mechanical Circulatory Support Technology

Technology to be evaluated in acute decompensated heart failure patients, where current treatment options remain ineffective and lacking

United statesErics fainBassem chehabGillian graftonProcyrion incJournal of the american college cardiologyDiuretics aloneEndovascular deviceAcute heart failureAscension via christiHenry ford hospitalChief executive officerAmerican collegeHeart failure

Procyrion enrolls first patient in mechanical circulatory support trial

Procyrion announced today that it enrolled the first patient in its investigational device exemption trial of the Aortix system.

United statesGillian graftonBassem chehabErics fainProcyrion aortixAscension via christi hospitalHenry ford hospital

Procyrion s Aortix Percutaneous Mechanical Circulatory Support Device to be Showcased at TCT 2021 Annual Meeting

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesErics fainProcyrion incPrnewswire procyrion incTranscatheter cardiovascular therapeuticsHallsa bTreat acute decompensated heart failureWorsening renalInnovation theaterInterventional heart failureAcute decompensated heartPreclinical modelPr newswireHeart failureMedical devices

Procyrion s Aortix Percutaneous Mechanical Circulatory Support Device to be Showcased at TCT 2021 Annual Meeting

/PRNewswire/ Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today the.

Erics fainProcyrion incHallsa bTreat acute decompensated heart failureWorsening renalInnovation theaterInterventional heart failureAcute decompensated heart failurePreclinical modelStatement regarding forward lookingHealth care amp hospitalsMedical pharmaceuticalsMedical equipment

vimarsana © 2020. All Rights Reserved.